{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01860417",
      "OrgStudyIdInfo": {
        "OrgStudyId": "TerCel005"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "2012-004444-30",
            "SecondaryIdType": "EudraCT Number"
          },
          {
            "SecondaryId": "Disc_allo_MSV",
            "SecondaryIdType": "Other Identifier",
            "SecondaryIdDomain": "Red TerCel"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Red de Terapia Celular",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)",
      "OfficialTitle": "Treatment of Lumbar Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Bone Marrow Mesenchymal Stromal Cells Expanded Using the Valladolid IBGM Procedure",
      "Acronym": "Disc_allo"
    },
    "StatusModule": {
      "StatusVerifiedDate": "April 2017",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "April 2017",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 2017",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "May 18, 2013",
      "StudyFirstSubmitQCDate": "May 18, 2013",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "May 22, 2013",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "April 25, 2017",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 26, 2017",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Red de Terapia Celular",
        "LeadSponsorClass": "INDUSTRY"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Citospin",
            "CollaboratorClass": "INDUSTRY"
          },
          {
            "CollaboratorName": "University of Valladolid",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "In this study we want to evaluate the clinical use of allogenic mesenchymal stem cells (MSC), obtained from bone marrow of healthy donors, for treatment of Degenerative Disc Disease (DDD). The trial is based in previous results with autologous MSC (Orozco et al., Transplantation 92: 822-828; 2011). Here we propose a phase I-II trial, prospective, randomized, blinded, and controlled for the treatment DDD using MSV, a Good Manufacturing Practice (GMP)-compliant expanded bone marrow MSC (MSV, PEI Num. 10-134). The assay consists of two arms with 12 patients each one. Patients in the experimental arm will be given a single intra-discal transplantation of MSV (25 millions in 2 ml). Control patients will be infiltrated in the paravertebral muscles close to the lesion with 2 ml of 1% mepivacain. We shall follow the evolution of pain, disability and quality of life as well as disc fluid content by Magnetic Resonance Imaging (T2-calibrated)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Degenerative Disc Disease",
          "Intervertebral Disc Disease",
          "Low Back Pain"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Degenerative Disc Disease,",
          "Intervertebral Disc Disease",
          "Low Back Pain",
          "Nucleus pulposus",
          "Stem cell",
          "Cellular therapy",
          "Regenerative therapy",
          "Mesenchymal stem cells",
          "Bone marrow",
          "Musculoskeletal Diseases",
          "Mesenchymal Stromal Cells (allogenic)"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Triple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "25",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Allogenic Mesenchymal Stromal Cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Mesenchymal stem cells (MSC) prepared from bone marrow from healthy donor expanded ex vivo for 3-4 weeks. Intradiscal injection of 25 millions MSC in 2 ml of saline",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Allogenic Mesenchymal Stromal Cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Mepivacaine",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Infiltration of paravertebral musculature close to the affected disc(s) with 2 ml of 1% Mepivacaine",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Mepivacaine"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Allogenic Mesenchymal Stromal Cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Allogenic Mesenchymal Stromal Cells"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Mesenchymal stem cells (MSC)",
                "MSC injection",
                "MSV (MSV=MSC prepared following Valladolid IBGM procedure)"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Mepivacaine",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mepivacaine"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Sham-treated comparator",
                "Mepivacaine is also known as Carbocaine",
                "Mepivacaine is also known as Polocaine"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Safety and tolerability",
            "PrimaryOutcomeDescription": "Number of participants with adverse events will be used as a measure of safety and tolerability. Adverse events reported: clinical review and questionaires for pain, disability and quality of life at 0, 3, 6 and 12 months",
            "PrimaryOutcomeTimeFrame": "up to one year"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Pain and disability evolution",
            "SecondaryOutcomeDescription": "Clinical review and questionaires (Visual Analogue Scales (VAS) and Oswestry questionnaires) at 0, 3, 6 and 12 months.",
            "SecondaryOutcomeTimeFrame": "up to 1 year"
          },
          {
            "SecondaryOutcomeMeasure": "Evolution of affected disc(s) by quantitative Magnetic Resonance Imaging (RMI)",
            "SecondaryOutcomeDescription": "RMI density measurements in T2 weighted images performed at 0, 6 and 12 months used as an indication of disc fluid content",
            "SecondaryOutcomeTimeFrame": "up to one year"
          },
          {
            "SecondaryOutcomeMeasure": "Llife quality evolution (Short Form (SF)-12 questionnaire)",
            "SecondaryOutcomeDescription": "SF-12 scores at 0, 3, 3 and 12 months",
            "SecondaryOutcomeTimeFrame": "up to 1 year"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDegenerative disease of one or two lumbar discs with predominant back pain after conservative treatment (physical and medical) for over 6 months.\nFibrous ring capable of holding the cell implantation, demonstrated by RMI image (stages 2, 3 and 4 of Adams).\nDecrease of disc height of more than 20% (radiographic measurement in side image).\nAbsence of spinal infection.\nHaematological and biochemical analysis wit no significant alterations that contraindicates intervention.\nThe patient is able to understand the nature of the study.\nInformed written consent of the patient.\n\nExclusion Criteria:\n\nAge over 75 or under 18 or legally dependent\nAllergy to gentamicin, or to bovine, cattle or horse serum.\nCongenital or acquired diseases leading to spine deformations that may upset cell application.\nSpinal segmental instability, spinal canal stenosis, isthmus pathology and other conditions that may compromise the study\nModic III changes on MRI images (31).\nOverweight with body mass index (mass in Kg/size in m2) greater than 35 (obesity grade II).\nPregnancy or breast-feeding\nNeoplasia\nImmunosuppression\nParticipation in another clinical trial or treatment with another investigational product within 30 days prior to inclusion in the study.\nOther conditions that may, according to medical criteria, discourage participation in the study.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "75 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Javier Garcia-Sancho, MD, PhD",
            "OverallOfficialAffiliation": "Scientific Park Foundation of University of Valladolid",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "David C Noriega, MD, PhD",
            "OverallOfficialAffiliation": "Hospital Clinico Universitario, Valladolid",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Ana Sanchez, MD, PhD",
            "OverallOfficialAffiliation": "Citospin",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "FRancisco Ardura, MD, PhD",
            "OverallOfficialAffiliation": "Hospital Clinico Universitario, Valladolid",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Hospital Clinico Universitario",
            "LocationCity": "Valladolid",
            "LocationZip": "47003",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Instituto de Biologia y Genetica Molecular",
            "LocationCity": "Valladolid",
            "LocationZip": "47003",
            "LocationCountry": "Spain"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "21792091",
            "ReferenceType": "background",
            "ReferenceCitation": "Orozco L, Soler R, Morera C, Alberca M, Sánchez A, García-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011 Oct 15;92(7):822-8. doi: 10.1097/TP.0b013e3182298a15."
          },
          {
            "ReferencePMID": "27661661",
            "ReferenceType": "derived",
            "ReferenceCitation": "Noriega DC, Ardura F, Hernández-Ramajo R, Martín-Ferrero MÁ, Sánchez-Lite I, Toribio B, Alberca M, García V, Moraleda JM, Sánchez A, García-Sancho J. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial. Transplantation. 2017 Aug;101(8):1945-1951. doi: 10.1097/TP.0000000000001484."
          }
        ]
      },
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Treatment of Degenerative Disc Disease with Autologous Mesenchymal Stem Cells",
            "SeeAlsoLinkURL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=orozco+and+garcia-sancho"
          },
          {
            "SeeAlsoLinkLabel": "Spanish Cell Therapy Network",
            "SeeAlsoLinkURL": "http://www.red-tercel.com"
          },
          {
            "SeeAlsoLinkLabel": "Citospin S.L. (MSV Cell Production)",
            "SeeAlsoLinkURL": "http://www.citospin.com"
          },
          {
            "SeeAlsoLinkLabel": "Intervertebral disk",
            "SeeAlsoLinkURL": "http://www.ncbi.nlm.nih.gov/mesh/?term=intervertebral"
          },
          {
            "SeeAlsoLinkLabel": "mesenchymal stem cells",
            "SeeAlsoLinkURL": "http://www.ncbi.nlm.nih.gov/mesh?term=cell%2C%20mesenchymal%20stem"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000013122",
            "ConditionMeshTerm": "Spinal Diseases"
          },
          {
            "ConditionMeshId": "D000055959",
            "ConditionMeshTerm": "Intervertebral Disc Degeneration"
          },
          {
            "ConditionMeshId": "D000001416",
            "ConditionMeshTerm": "Back Pain"
          },
          {
            "ConditionMeshId": "D000017116",
            "ConditionMeshTerm": "Low Back Pain"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010146",
            "ConditionAncestorTerm": "Pain"
          },
          {
            "ConditionAncestorId": "D000009461",
            "ConditionAncestorTerm": "Neurologic Manifestations"
          },
          {
            "ConditionAncestorId": "D000001847",
            "ConditionAncestorTerm": "Bone Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M3866",
            "ConditionBrowseLeafName": "Back Pain",
            "ConditionBrowseLeafAsFound": "Back Pain",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18585",
            "ConditionBrowseLeafName": "Low Back Pain",
            "ConditionBrowseLeafAsFound": "Low Back Pain",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M12218",
            "ConditionBrowseLeafName": "Pain",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M27558",
            "ConditionBrowseLeafName": "Intervertebral Disc Degeneration",
            "ConditionBrowseLeafAsFound": "Degenerative Disc Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M15071",
            "ConditionBrowseLeafName": "Spinal Diseases",
            "ConditionBrowseLeafAsFound": "Disc Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11556",
            "ConditionBrowseLeafName": "Neurologic Manifestations",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4278",
            "ConditionBrowseLeafName": "Bone Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000008619",
            "InterventionMeshTerm": "Mepivacaine"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000779",
            "InterventionAncestorTerm": "Anesthetics, Local"
          },
          {
            "InterventionAncestorId": "D000000777",
            "InterventionAncestorTerm": "Anesthetics"
          },
          {
            "InterventionAncestorId": "D000002492",
            "InterventionAncestorTerm": "Central Nervous System Depressants"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000018689",
            "InterventionAncestorTerm": "Sensory System Agents"
          },
          {
            "InterventionAncestorId": "D000018373",
            "InterventionAncestorTerm": "Peripheral Nervous System Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M10752",
            "InterventionBrowseLeafName": "Mepivacaine",
            "InterventionBrowseLeafAsFound": "Flare",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M3259",
            "InterventionBrowseLeafName": "Anesthetics",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3261",
            "InterventionBrowseLeafName": "Anesthetics, Local",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "CNSDep",
            "InterventionBrowseBranchName": "Central Nervous System Depressants"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}